In contrast, PI3K signaling was enriched in 69.3 of the cancer cells in the non-responder’s tumors prior to cycle 1, and decreased to 64.3% after cycle 2, while the remaining cells were enriched in the metabolism archetype (Fig. 3D). The gene discussed is PIK3CA; the disease is cancer.